Journal of the American Chemical Society
ARTICLE
E.R. and to C.G.M.), BBSRC/EaStChem (studentship to S.T.)
and EPSRC (studentship to N.C.).
amounts of 16O2 introduced during handling and/or exchange processes
described below.
(24) Hayaishi, O.; Hirata, F.; Ohnishi, T.; Henry, J. P.; Rosenthal, I.;
Katoh, A. J. Biol. Chem. 1977, 252, 3548–50.
(25) Hayaishi, O.; Rothberg, S.; Mehler, A. H.; Saito, Y. J. Biol. Chem.
1957, 229, 889–96.
(26) Ronsein, G. E.; de Oliveira, M. C.; de Medeiros, M. H.; Di
Mascio, P. J. Am. Soc. Mass Spectrom. 2009, 20, 188–97.
(27) It is not known whether addition occurs at C2 or C3 of the
substrate; both options are feasible for both mechanisms in Scheme 3
(but we only show one in each case).12,13,16,26
(28) Yanagisawa, S.; Horitani, M.; Sugimoto, H.; Shiro, Y.; Okada,
N.; Ogura, T. Faraday. Disc. 2010, 148, 1–9.
(29) Yanagisawa, S.; Yotsuya, K.; Hashiwaki, Y.; Horitani, M.;
Sugimoto, H.; Shiro, Y.; Appelman, E. H.; Ogura, T. Chem. Lett. 2010,
39, 36–37.
(30) Chen, H.; Ikeda-Saito, M.; Shaik, S. J. Am. Chem. Soc. 2008,
130, 14778–90.
(31) Efimov, I.; Basran, J.; Thackray, S. J.; Handa, S.; Mowat, C. G.;
Raven, E. L. Biochemistry 2011, 50, 2717–24.
(32) Lai, W.; Shaik, S. J. Am. Chem. Soc. 2011, 113, 5444–5452.
(33) Chung, L. W.; Li, X.; Sugimoto, H.; Shiro, Y.; Morokuma, K.
J. Am. Chem. Soc. 2010, 132, 11993–2005.
(34) Hamilton, G. A. Advan. Enzymol. Relat. Areas Mol. Biol. 1969,
32, 55–96.
(35) Nakagawa, M.; Watanabe, H.; Kodato, S.; Okajima, H.; Hino,
T.; Flippen, J. L.; Witkop, B. Proc. Natl. Acad. Sci. U.S.A. 1977, 74,
4730–3.
(36) Savige, W. E. Aust. J. Chem. 1975, 28, 2275–2287.
(37) The same tricylic compound is also known to be generated via
formation of a 3-peroxyindole species, and is well-known in indole
chemistry.11,34,36 However, this reaction requires photolytic conditions
and a sensitizer for formation of (the much more reactive) singlet oxygen,
and we assume that formation of singlet oxygen is not possible under the
steady state turnover conditions of our experiments.
’ REFERENCES
(1) Sono, M.; Roach, M. P.; Coulter, E. D.; Dawson, J. H. Chem. Rev.
1996, 96, 2841–2887.
(2) Rohrig, U. F.; Awad, L.; Grosdidier, A.; Larrieu, P.; Stroobant, V.;
Colau, D.; Cerundolo, V.; Simpson, A. J.; Vogel, P.; Van den Eynde, B. J.;
Zoete, V.; Michielin, O. J. Med. Chem. 2010, 53, 1172–89.
(3) Macchiarulo, A.; Camaioni, E.; Nuti, R.; Pellicciari, R. Amino
Acids 2009, 37, 219–29.
(4) Katz, J. B.; Muller, A. J.; Prendergast, G. C. Immunol Rev 2008,
222, 206–21.
(5) Kotake, Y.; Masayama, I. Z. Physiol. Chem. 1936, 243, 237–44.
(6) Cady, S. G.; Sono, M. Arch. Biochem. Biophys. 1991, 291, 326–33.
(7) Sugimoto, H.; Oda, S.-i.; Otsuki, T.; Hino, T.; Yoshida, T.; Shiro,
Y. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 2611–2616.
(8) Chauhan, N.; Basran, J.; Efimov, I.; Svistunenko, D. A.; Seward,
H. E.; Moody, P. C. E.; Raven, E. L. Biochemistry 2008, 47, 4761–4769.
(9) Thackray, S. J.; Bruckmann, C.; Anderson, J. L.; Campbell, L. P.;
Xiao, R.; Zhao, L.; Mowat, C. G.; Forouhar, F.; Tong, L.; Chapman, S. K.
Biochemistry 2008, 47, 10677–10684.
(10) Terentis, A. C.; Thomas, S. R.; Takikawa, O.; Littlejohn, T. K.;
Truscott, R. J. W.; Armstrong, R. S.; Yeh, S.-R.; Stocker, R. J. Biol. Chem.
2002, 277, 15788–15794.
(11) Joule, J. A.; Mills, K. 2000, Blackwell, 4th ed.
(12) Chung, L. W.; Li, X.; Sugimoto, H.; Shiro, Y.; Morokuma, K.
J. Am. Chem. Soc. 2008, 130, 12299–309.
(13) Chauhan, N.; Thackray, S. J.; Rafice, S. A.; Eaton, G.; Lee, M.;
Efimov, I.; Basran, J.; Jenkins, P. R.; Mowat, C. G.; Chapman, S. K.;
Raven, E. L. J. Am. Chem. Soc. 2009, 131, 4186–7.
(14) Davydov, R. M.; Chauhan, N.; Thackray, S. J.; Anderson, J. L.;
Papadopoulou, N. D.; Mowat, C. G.; Chapman, S. K.; Raven, E. L.;
Hoffman, B. M. J. Am. Chem. Soc. 2010, 132, 5494–500.
(15) Capece, L.; Lewis-Ballester, A.; Batabyal, D.; Di Russo, N.; Yeh,
S. R.; Estrin, D. A.; Marti, M. A. J Biol Inorg Chem 2010, 15, 811–23.
(16) Lewis-Ballester, A.; Batabyal, D.; Egawa, T.; Lu, C.; Lin, Y.;
Marti, M. A.; Capece, L.; Estrin, D. A.; Yeh, S. R. Proc. Natl. Acad. Sci.
U.S.A. 2009, 106, 17371–6.
(17) Basran, J.; Rafice, S. A.; Chauhan, N.; Efimov, I.; Cheesman,
M. R.; Ghamsari, L.; Raven, E. L. Biochemistry 2008, 47, 4752–4760.
(18) Forouhar, F.; Anderson, J. L.; Mowat, C. G.; Vorobiev, S. M.;
Hussain, A.; Abashidze, M.; Bruckmann, C.; Thackray, S. J.; Seetharaman,
J.; Tucker, T.; Xiao, R.; Ma, L. C.; Zhao, L.; Acton, T. B.; Montelione,
G. T.; Chapman, S. K.; Tong, L. Proc. Natl. Acad. Sci. U.S.A. 2007,
104, 473–8.
(38) Saito, I.; Matsuura, T.; Nakagawa, M.; Hino, T. Acc. Chem. Res.
1977, 10.
(39) While this work was being prepared for publication, Chung and
co-workers published QM/MM data supporting epoxide formation and
presented a proposal for conversion of the epoxide to NFK.33 Their
mechanism, which is similar but not the same as that presented here, also
implicates ring opening and in addition they suggest proton transfer
+
from/to the NH3 group of the substrate, which would be consistent
with our recent spectroscopic data.14 These authors also put forward a
proposal for C2-C3 bond cleavage, but in this case a mixed heterocyclic/
radical mechanism is proposed. From a chemical standpoint, we believe
that a purely heterocyclic (two electron) mechanism, Scheme 3, is more
likely.
(19) Papadopoulou, N. D.; Mewies, M.; McLean, K. J.; Seward,
H. E.; Svistunenko, D. A.; Munro, A. W.; Raven, E. L. Biochemistry 2005,
44, 14318–14328.
(40) Zhu, X.; van Pee, K. H.; Naismith, J. H. J. Biol. Chem. 2010, 285,
21126–33.
(41) Meunier, B.; de Visser, S. P.; Shaik, S. Chem Rev 2004, 104,
3947–80.
(42) Montellano, P. R. O. Cytochrome P450: structure, mechanism
and biochemistry; 3rd ed. ed.; Kluwer Academic/Plenum: New York,
2005.
(43) Lanza, D. L.; Yost, G. S. Drug Metab. Dispos. 2001, 29, 950–3.
(44) Skordos, K. W.; Skiles, G. L.; Laycock, J. D.; Lanza, D. L.; Yost,
G. S. Chem. Res. Toxicol. 1998, 11, 741–9.
(20) Nakagawa, M.; Kato, S.; Kataoka, S.; Kadato, S.; Watanabe, H.;
Okajima, H.; Hino, T.; Witkop, B. Chem. Pharm. Bull. 1981, 29, 1013–1026.
(21) Williamson, B. L.; Benson, L. M.; Tomlinson, A. J.; Mayeno,
A. N.; Gleich, G. J.; Naylor, S. Toxicol. Lett. 1997, 92, 139–48.
(22) An alternative explanation is that the 221 species is derived
from a small substoichiometric amount of off-pathway epoxide inter-
mediate (perhaps a feature of the way we conducted the mass spectro-
metry experiments) that forms during catalysis, whereas the majority of
the active sites proceed through another, productive mechanism
(producing just NFK). We cannot categorically rule out this possibility,
although we have observed the 221 species under different experimental
conditions for turnover and with different enzymes, both with and
without TCA treatment.
(23) In these 18O2 experiments with L-Trp, we also see minor peaks
eluting with masses of m/z = 237 and m/z = 221, although the presence/
absence of these peaks and their intensities vary from sample to sample.
These peaks correspond to the 16O2 “equivalents” of the m/z = 241 and
m/z = 223 peaks as described above, and most likely arise from trace
16257
dx.doi.org/10.1021/ja207066z |J. Am. Chem. Soc. 2011, 133, 16251–16257